Author:
Freund Mathias,Giller Simone,Hinrichs Fokke,Baars Axel,Meran Johannes,Körfer Alfred,Link H.,Poliwoda Hubert
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference44 articles.
1. Amadori S, Papa G, Miniero R, Meloni G, Petti MC, Mandelli F (1988) Intermediate-dose ara-C (IdAC) with sequential mitoxantrone (Mitox) in acute myeloid leukemia (AML) (abstract). Proc Am Soc Clin Oncol 7:A670
2. Arlin ZA, Ahmed T, Mittelman A, Feldman E, Mehta R, Weinstein P, Rieber E, Sullivan P, Baskind P (1987) A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia. J Clin Oncol 5:371–375
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnik HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med 103:626–629
4. Berman E, Arlin ZA, Gaynor J, Miller W, Gee T, Kempin SJ, Mertelsmann R, Andreeff M, Reich L, Nahmias N, et al. (1989) Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol. Leukemia 3:115–121
5. Breithaupt H, Pralle H, Eckhardt T, von Hattingberg M, Schick J, Loeffler H (1982) Clinical results and pharmacokinetics of high dose cytosine arabinoside (HD ARA-C). Cancer 50:1248–1257
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献